Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Michael Shlonsky, DPM

440.695.4000

Michael  Shlonsky, DPM

Appointed: 2010

Michael Shlonsky, DPM
Department: Orthopaedic Surgery
Associate Staff
Location: Richard E. Jacobs Health Center
33100 Cleveland Clinic Blvd.
Avon, OH 44011
WorkAppointment:440.695.4000
DeskDesk:440.695.4121
WorkFax:440.695.4189
Michael Shlonsky, DPM
Department: Orthopaedic Surgery
Location: Westlake Medical Campus Building A
850 Columbia Road
Westlake, OH 44145
WorkAppointment:440.695.4000
DeskDesk:440.695.4121
WorkFax:440.695.4189
Surgeon:
Yes
Treats:
Adults Only

Education & Fellowships

Internship - New York College of Podiatric Medicine
Podiatric Medicine and Surgery
NY USA
1982
Residency - Coney Island Hospital
Podiatric Medicine and Surgery
Brooklyn, NY USA
1982
Medical School - Ohio College of Podiatric Medicine
Cleveland, OH USA
1981
Undergraduate - Kent State University
Kent, OH USA
1977

Certifications

  • American Board of Podiatric Surgery- Foot Surgery

Specialty Interests

General podiatry, forefoot surgery, musculoskeletal and dermatologic conditions of the foot, wound management, joint replacement of the toes

Treatment & Services

  • Ankle Pathology
  • Arthritis, Surgical And Non Surgical Treatment
  • Bunion Surgery
  • Conservative Treatment of the Foot
  • Diabetic Foot Care
  • Diabetic Foot Screening
  • Diabetic Foot Ulcer Treatment
  • Foot Surgery
  • Forefoot Surgery
  • Fracture Care
  • Heel Injections
  • Ingrown Toenail Removal
  • Musculoskeletal Foot Pathology
  • Plantars Wart Treatment
  • Podiatry
  • Reconstructive Foot And Ankle Surgery
  • Surgery
  • Surgical Treatment of the Foot
  • Trauma Treatment
  • Viscosupplementation

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/30/2014, Dr. Shlonsky has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English